Bushra Bashir

Editorial Board Member

Name: Dr. Bushra Bashir

Designation:
Assistant Professor

Affiliation:
Bombay Institute of Pharmacy and Research,
Thane, Maharashtra, India

Institutional Address:
Bombay Institute of Pharmacy and Research,
Next to Lodha Panacea, Sandap Gaon,
Manpada Diva Road, Dombivli East,
Thane, Maharashtra – 421204, India

Email: ✉️ [email protected]

Academic Profiles:

Professional Overview

Dr. Bushra Bashir is an academician and researcher in pharmacology and pharmaceutical sciences, with research interests spanning neuroscience, neuropharmacology, nanotechnology, drug delivery, phytomedicine, pre-clinical research, cancer research, and the gut-brain axis. She currently serves as an Assistant Professor at the Bombay Institute of Pharmacy and Research, Thane, Maharashtra.

Her research focuses particularly on the development and evaluation of advanced drug-delivery approaches for poorly soluble and gastrointestinal-labile drugs, including nanotechnology-based formulations and brain-targeted delivery systems. Her academic work also covers neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, nanomedicine, phytoconstituent-based therapeutics, microbiome-related approaches, and experimental pharmacology.

She has contributed to research and review literature in pharmacology, neuroscience, drug delivery, neurodegenerative diseases, nanomedicine, phytomedicine, analytical methods, and related biomedical areas. Her work includes original research articles, review papers, conference abstracts, book chapters, and scholarly contributions to national and international scientific platforms.

Research Interests

  • Neuroscience and Neuropharmacology
  • Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson's Disease
  • Nanotechnology and Nanomedicine
  • Advanced Drug Delivery Systems
  • Brain-Targeted Drug Delivery
  • Pre-clinical Studies
  • Phytomedicine and Phytopharmacology
  • Gut-Brain Axis and Gut Microbiome
  • Postbiotics and Probiotics
  • Cancer Research
  • Pharmacology and Experimental Therapeutics

Academic Qualifications

  • Ph.D. in Pharmacology – Lovely Professional University, 2026
  • M.Pharm in Pharmacology – Al-Ameen College of Pharmacy, Bengaluru, 2021
  • B.Pharm – University of Kashmir, India, 2019

Research and Academic Expertise

  • Experimental and pre-clinical pharmacology
  • Neuropharmacology and neuroprotection
  • Alzheimer's and Parkinson's disease research
  • Nanotechnology-based pharmaceutical formulations
  • Nanostructured lipid carriers and nanoemulsions
  • Self-nanoemulsifying drug-delivery systems
  • Brain-targeted drug-delivery approaches
  • Phytoconstituent-based therapeutic approaches
  • Gut microbiome and gut-brain axis research
  • Postbiotic and probiotic therapeutic approaches
  • Pharmacokinetic and pharmacodynamic evaluation
  • Analytical and bioanalytical method development

Research and Scholarly Contributions

Dr. Bushra Bashir has contributed extensively to pharmaceutical and biomedical research through original research articles, review papers, conference abstracts, book chapters, and scientific presentations. Her scholarly work has appeared in journals covering pharmacology, ageing research, neuroscience, drug-delivery science, nanotechnology, molecular biology, pharmaceutical analysis, phytochemistry, and related disciplines.

Her recent research has addressed topics including neuroprotective drug-delivery systems, nanomedicine for Alzheimer's and Parkinson's diseases, postbiotics and the gut microbiome, phytoconstituent-based therapeutics, cancer biology, novel analytical approaches, and advanced nanoformulation strategies.

Selected Research Areas and Contributions

  • Nanomedicine-based neuroprotective approaches for Alzheimer's and Parkinson's diseases.
  • Development and evaluation of nanoemulsions, nanostructured lipid carriers and related advanced drug-delivery systems.
  • Pre-clinical evaluation of phytoconstituents and pharmacological agents for neurodegenerative disorders.
  • Research on gut microbiome, postbiotics, probiotics and their potential role in neurological diseases.
  • Investigation of phytomedicine and natural compounds for neurological and oncological applications.
  • Research involving pharmacokinetic, pharmacodynamic and bioanalytical assessment of pharmaceutical formulations.
  • Development of brain-targeted and oral delivery strategies for challenging therapeutic compounds.

Selected Scholarly Publications

  • Autophagy in Thyroid Cancer: Immune Suppression and Drug Resistance – Drug Resistance Updates, 2026.
  • Advocating Gut-Retina Connection and Microbiota-Mediated Pathways in Management of Age-Related Macular Degeneration: Preclinical to Clinical Perspective – Ageing Research Reviews, 2026.
  • Nanomedicine-Enabled Neuroprotection: Therapeutic Role of Berberine in Neurodegenerative Diseases – Molecular Biology Reports, 2026.
  • Neuroprotective Role of Cyanidin in Alzheimer's and Parkinson's Disease: Current Insights and the Road Ahead – Inflammopharmacology, 2026.
  • Exosomes as an Emerging Biological Nanoplatform in the Management of Alzheimer's Disease: Breakthroughs and Bottlenecks – Journal of Drug Delivery Science and Technology, 2026.
  • Harnessing the Neuroprotective Effect of Oral Administration of Benfotiamine in MPTP-Induced Parkinson's Disease in Rats – European Journal of Pharmacology, 2024.
  • Formulation and Optimization of Fisetin Nanoemulsion for the Treatment of Alzheimer's Disease in Rats: Pharmacokinetic and Pharmacodynamic Assessment – Journal of Drug Delivery Science and Technology, 2024.
  • Tailoring the Biomarkers of Alzheimer's Disease Using a Gut Microbiome-Centric Approach: Preclinical, Clinical and Regulatory Perspectives – Ageing Research Reviews, 2025.

Books and Book Chapters

  • Nanoemulsions for the Management of COPD – Academic Press, 2026.
  • Natural Medicines (Phytoconstituents) and Probiotics as the Future of Alzheimer's Disease – Springer Nature, 2025.
  • Heavy Metals and Alzheimer's Disease: A Review – Academic Press, 2025.
  • Mechanisms of Drug Delivery in Self-Nanoemulsifying Drug Delivery Systems – Taylor & Francis, 2025.

Conference and Scientific Presentations

Dr. Bashir has presented research at national and international scientific meetings, including Alzheimer's Association International Conference events and conferences covering pharmaceutical sciences, neuroscience, drug delivery and biomedical research.

  • Xanthohumol-loaded self-nanoemulsifying drug-delivery system for neuroprotection in Alzheimer's disease – AAIC 2024.
  • Exploring the neuroprotective effects of xanthohumol and quercetin for Alzheimer's disease – AAIC 2025.
  • Parkinson's disease and molecular targets: challenges and future directions – ICSPC 2023.
  • Role of postbiotics in the management of Parkinson's disease – ICRAHS 2024.
  • Role of the gut microbiome in the management of Parkinson's disease – ICP 2024.
  • Synbiotics as solidifying excipients for lipid-based nanoparticles and gut immunomodulation – CRS 2025.

Editorial and Peer-Review Service

Dr. Bushra Bashir is actively involved in scholarly peer review and has served as a reviewer for journals indexed in major scientific databases. Her reviewing activities span neuroscience, pharmacology, toxicology, nanobiotechnology, neurodegenerative disorders and related biomedical disciplines.

Her reviewer experience includes journals published predominantly by Springer Nature, including BMC Neurology, Molecular Neurobiology, Inflammopharmacology, Metabolic Brain Disease, Journal of Nanobiotechnology, Neurotoxicity Research, Discover Neuroscience, Discover Nano, and Molecular Biology Reports, among others.

Research Training and Professional Development

  • Seven-day workshop on the conduct of pre-clinical research with ethical practices and biomedical waste management, Lovely Professional University, April 2024.

Last Updated: 12 September 2026